Organon shelves con­tra­cep­tive with 'nat­u­ral' es­tro­gen

Organon’s at­tempt to re­vive a once-re­ject­ed “nat­ur­al” con­tra­cep­tive is over, a spokesper­son con­firmed to End­points News.

The Mer­ck women’s health spin­off has ter­mi­nat­ed a Phase …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.